Presentation – Founders
Adocia was founded in December 2005 by Gérard Soula and his two sons, Olivier and Rémi.
These three highly skilled scientists each have a PhD degree in polymer science and they have a strong track record in protein delivery. Based on this expertise, they have designed innovative protein formulations for regenerative medicine and chronic disease: BioChaperone®, a “Molecular Delivery System of Therapeutic Proteins”.
PhD, MBA – President and CEO
Gérard Soula has a PhD in Organic chemistry and has an MBA from IAE (Aix Marseille).
He founded Flamel Technologies (in 1990), a biotech company specialized in Drug Delivery and listed on Nasdaq. He was the CEO and Director of Research until June 2005. When he left, Flamel had 250 employees, $100M cash in bank and a market capitalization of $500M. Flamel Technologies’ success is based on the performances of its platforms, Micropump and Medusa.
Furthermore, Gérard Soula has a strong track record in negotiating license agreements in innovating technologies with big pharma groups (Novo Nordisk, Bristol Myers Squibb, GlaxoSmithKline etc). He is the co-author of more than 120 patents.
PhD, MBA – Deputy General Manager – R&D Director
Olivier Soula has a PhD in polymer science, graduated from ENSIC Mulhouse, and has an MBA from IAE, Lyon.
He worked for 8 years at Flamel Technologies as Director of the Nanotechnologies department. He led the development of Medusa, a prolonged release platform of therapeutic proteins and successfully conducted clinical trials for three of those projects.
Olivier is co-author of nearly 40 patents relating to protein delivery. He has worked for 16 years on insulin formulation.
PhD, MBA – Business Development and Intellectual Property Director
Rémi Soula has a PhD in polymer science. He did his Post-Doc at the Max Planck Institute in Postdam and has an MBA from HEC Paris. Rémi spent 3 years at Flamel Technologies as senior manager in Polymer Synthesis.
Today, as Director of Business Development and Intellectual Property Director at Adocia, he is the co-author of more than 30 patents and 6 scientific publications.